Cargando…

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

The SARS-CoV-2 Omicron variant has demonstrated enhanced transmissibility and escape of vaccine-derived immunity. Although first-generation vaccines remain effective against severe disease and death, robust evidence on vaccine effectiveness (VE) against all Omicron infections, irrespective of sympto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Jonathan J., Cheng, Samuel M. S., Leung, Kathy, Lee, Cheuk Kwong, Hachim, Asmaa, Tsang, Leo C. H., Yam, Kenny W. H., Chaothai, Sara, Kwan, Kelvin K. H., Chai, Zacary Y. H., Lo, Tiffany H. K., Mori, Masashi, Wu, Chao, Valkenburg, Sophie A., Amarasinghe, Gaya K., Lau, Eric H. Y., Hui, David S. C., Leung, Gabriel M., Peiris, Malik, Wu, Joseph T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941049/ https://www.ncbi.nlm.nih.gov/pubmed/36652990 http://dx.doi.org/10.1038/s41591-023-02219-5

Ejemplares similares

Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants
por: Wong, Carlos K H, et al.
Publicado: (2023)

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong
por: Xie, Ruopeng, et al.
Publicado: (2023)

Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents
por: Leung, Daniel, et al.
Publicado: (2023)

Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections
por: Tso, Winnie W.Y., et al.
Publicado: (2022)

Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
por: Wong, Carlos K H, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
por: Rosa Duque, Jaime S., et al.
Publicado: (2022)

Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
por: Rosa Duque, Jaime S., et al.
Publicado: (2022)

Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022
por: Mefsin, Yonatan M., et al.
Publicado: (2022)

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine
por: Leung, Nancy H L, et al.
Publicado: (2022)

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
por: Mu, Xiaofeng, et al.
Publicado: (2022)

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
por: Hachim, Asmaa, et al.
Publicado: (2022)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
por: Rössler, Annika, et al.
Publicado: (2022)

Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
por: Wong, Carlos K H, et al.
Publicado: (2022)

Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong
por: Leung, Daniel, et al.
Publicado: (2023)

Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain
por: Wu, Chao, et al.
Publicado: (2020)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
por: Wu, Chao, et al.
Publicado: (2021)

Structural insights into RNA recognition and activation of RIG-I-like receptors
por: Leung, Daisy W, et al.
Publicado: (2012)

When your cap matters: structural insights into self vs non-self recognition of 5′ RNA by immunomodulatory host proteins
por: Leung, Daisy W, et al.
Publicado: (2016)

Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue
por: Valkenburg, Sophie A., et al.
Publicado: (2021)

Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
por: Hui, Kenrie P.Y., et al.
Publicado: (2022)

The Transmission Dynamics of Tuberculosis in a Recently Developed Chinese City
por: Wu, Peng, et al.
Publicado: (2010)

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial
por: Leung, Nancy H L, et al.
Publicado: (2023)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
por: Pedersen, Rune M., et al.
Publicado: (2022)

Predicting Future Blood Demand from Thalassemia Major Patients in Hong Kong
por: Lau, Eric H. Y., et al.
Publicado: (2013)

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
por: Hachmann, Nicole P., et al.
Publicado: (2022)

Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study
por: Tsang, Tim K, et al.
Publicado: (2020)

Protection against Reinfection with the Omicron BA.2.75 Subvariant
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
por: Hachmann, Nicole P., et al.
Publicado: (2022)

Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients
por: Ferreira, Victor H., et al.
Publicado: (2023)

Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Detection of SARS-CoV-2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays
por: Sit, Brian H.M., et al.
Publicado: (2022)

Aptamers in Virology: Recent Advances and Challenges
por: Binning, Jennifer M., et al.
Publicado: (2012)

Avian Influenza and Ban on Overnight Poultry Storage in Live Poultry Markets, Hong Kong
por: Leung, Y.H. Connie, et al.
Publicado: (2012)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A., et al.
Publicado: (2021)

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Identifying Key Transmission Route of Avian Influenza A(H9N2) in Live Poultry Markets
por: Lau, Eric H., et al.
Publicado: (2017)

Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets
por: Hachim, Asmaa, et al.
Publicado: (2021)

Social contact patterns relevant to the spread of respiratory infectious diseases in Hong Kong
por: Leung, Kathy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2t9cp4899oa8qo3gsv6i9b7m7h